9 Oak Park Drive
United States - Map
Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), which consists of the OmniPod, a disposable insulin infusion device that integrates an infusion set, automated cannula insertion, insulin reservoir, drive mechanism, and batteries; and a handheld, wireless personal diabetes manager. It is also involved in the distribution of durable medical equipment, including blood glucose testing supplies, insulin pumps, pump supplies, pharmaceuticals, and other products for the management and treatment of diabetes. The company sells its OmniPod System directly to patients through referrals from healthcare professionals and through patient leads, as well as through third-party distributors. Insulet Corporation was founded in 2000 and is based in Bedford, Massachusetts.
|Insulet Corporation’s ISS Governance QuickScore as of Jan 1, 2015 is 10. The pillar scores are Audit: 10; Board: 4; Shareholder Rights: 10; Compensation: 6.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Charles T. Liamos ,
Director of Advanced Technology and Director
|Mr. R. Anthony Diehl Esq.,
Gen. Counsel and Sec.
|Mr. Peter J. Devlin ,
|Mr. Patrick J. Sullivan ,
Chief Exec. Officer, Pres and Director
|Ms. Allison Dorval ,
Chief Financial Officer
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|